Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation

Can J Cardiol. 2013 Oct;29(10):1330.e13. doi: 10.1016/j.cjca.2013.01.002. Epub 2013 Mar 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anisoles / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / physiopathology
  • Electrocardiography*
  • Europe
  • Flecainide / therapeutic use*
  • Humans
  • Practice Guidelines as Topic
  • Propafenone / therapeutic use*
  • Pyrrolidines / therapeutic use*

Substances

  • Anisoles
  • Anti-Arrhythmia Agents
  • Pyrrolidines
  • Propafenone
  • vernakalant
  • Flecainide